Boston Scientific Corporation
BSX · Healthcare · Health Care
Updated 26 min ago · data delayed ≥15 min
IconicScore
ProprietaryRanked #198 of 500 by Iconic Score · #24 of 59in its sector. IconicAlpha’s proprietary brand-intelligence metric — a multi-model blend of scale, market attention, category leadership, and AI-analyzed brand visibility.
Get the free morning email
The biggest IconicScore™ gainer and loser, plus the strongest and weakest sectors, in your inbox before the open. See a sample →
Price performance
Export history · AnalystThis insight is part of the Analyst tier — unlock the IconicScore vs. price overlay, side-by-side comparison, and CSV export.
Upgrade to AnalystThis is part of the Enterprise tier — benchmark your IconicScore against sector peers, claim your profile, and manage how your brand appears on the wall.
Upgrade to EnterpriseIconic Profile
Boston Scientific Corporation (BSX) is a leading global medical technology company that develops, manufactures, and markets innovative devices and solutions across various healthcare sectors, including cardiovascular, rhythm management, and urology. With a market capitalization of $63.9 billion, Boston Scientific is well-positioned in the healthcare industry, leveraging advanced technologies to improve patient outcomes and enhance procedural efficiency. The company's extensive portfolio includes products for minimally invasive surgeries and therapies, addressing significant medical needs and contributing to the advancement of healthcare practices. Boston Scientific's commitment to research and development, along with its strategic partnerships and acquisitions, underscores its importance in the evolving landscape of medical technology, making it a key player in driving innovation and improving quality of care globally.
IconicOracleAI™ Brief
Boston Scientific Corp (BSX) currently holds an Iconic Score of 49, reflecting moderate brand recognition and sentiment amid a market cap of $65.9 billion. The recent price decline of 3.03% may be influenced by broader market dynamics and competitive pressures, particularly highlighted by the acquisition of K2M Group by Stryker. Despite these challenges, the company's strong brand visibility score of 85/100 indicates a solid presence in the medical device sector, which may help sustain interest among stakeholders.
AI-generated explanation of current score drivers. Not investment advice.
Enterprise tier: claim your logo to manage how your brand is represented.